This is the authors' abstract. We don't add key points for this paper.
Background: Botulinum Toxin A (BTX-A) has been found to improve blood flow perfusion. This study aimed to find in literature the use of BTX-A in Plastic Surgery and in particular its use to improve blood flow perfusion.Methods: We read the article “Effects of Botulinum Toxin A on the blood flow in expanded rat skin” and starting from this article we searched in the literature all the articles talking about the use of BTX-A to improve blood flow perfusion.Results: BTX-A increase the expression of VEGF, CD-31 and INOS. Moreover BTX-A selective suppress sympathetic neurons of the cutaneous microcirculation. We found 13 studies that confirm the effects of Botulinum Toxin A in improving blood flow perfusion of cutaneous and myocutaneous flaps.Conclusion: We think that in the future we could start to use BTX-A in these fields of plastic surgery, but we really need to understand good dosages and standardize them, see which are the effects on long-term outcomes, and put on randomized trials providing high-level evidence about the range of dosages in which we are safe to use BTX-A and asses the risk-benefit ratio in humans and the cost-benefit ratio.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Fasano et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: